City

Barcelona (1)

Dallas (1)

Houston (1)

Lake Success (1)

New York (1)

Philadelphia (1)

Condition

Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Millennium Pharmaceuticals, Inc. (1)

Collaborator

Intervention

alisertib (1)

docetaxel (1)

mln1117 (1)

paclitaxel (1)

tak-659 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

advanced and metastatic gastric or gastroesophageal adenocarcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma Trial in Spain, United States (MLN1117, TAK-659, Alisertib)

Terminated

Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma

MLN1117
+4 more

Lake Success, New York
+5 more

Aug 19, 2019